Search details
1.
Thrombospondin-1 promotes hemostasis through modulation of cAMP signaling in blood platelets.
Blood
; 137(5): 678-689, 2021 02 04.
Article
in English
| MEDLINE | ID: mdl-33538796
2.
Atherogenic lipid stress induces platelet hyperactivity through CD36-mediated hyposensitivity to prostacyclin: the role of phosphodiesterase 3A.
Haematologica
; 105(3): 808-819, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31289200
3.
Dyslipidemia-associated atherogenic oxidized lipids induce platelet hyperactivity through phospholipase Cγ2-dependent reactive oxygen species generation.
Platelets
; 30(4): 467-472, 2019.
Article
in English
| MEDLINE | ID: mdl-29733744
4.
Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade.
Blood
; 125(17): 2693-703, 2015 Apr 23.
Article
in English
| MEDLINE | ID: mdl-25710879
5.
cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA-Rho kinase-MLC phosphatase signaling pathway.
Blood
; 122(20): 3533-45, 2013 Nov 14.
Article
in English
| MEDLINE | ID: mdl-24100445
6.
Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways.
Blood
; 122(4): 580-9, 2013 Jul 25.
Article
in English
| MEDLINE | ID: mdl-23699602
7.
Acute hypertriglyceridemia induces platelet hyperactivity that is not attenuated by insulin in polycystic ovary syndrome.
J Am Heart Assoc
; 3(1): e000706, 2014 Feb 28.
Article
in English
| MEDLINE | ID: mdl-24584741
Results
1 -
7
de 7
1
Next >
>>